{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:30:42Z","timestamp":1785864642598,"version":"3.56.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins & Other Lipid Mediators"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.prostaglandins.2016.07.006","type":"journal-article","created":{"date-parts":[[2016,7,15]],"date-time":"2016-07-15T19:48:03Z","timestamp":1468612083000},"page":"24-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["PGE1 improves diabetic peripheral neuropathy in patients with type 2 diabetes"],"prefix":"10.1016","volume":"126","author":[{"given":"Jin-Dan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-Lan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kok-Onn","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Hua","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pmr.2007.10.010","article-title":"The spectrum of diabetic neuropathies","volume":"19","author":"Tracy","year":"2008","journal-title":"Phys. Med. Rehabil. Clin. N. Am."},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0010","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2337\/diacare.28.4.956","article-title":"Diabetic neuropathies: a statement by the American Diabetes Association","volume":"28","author":"Boulton","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0015","first-page":"1811","article-title":"Genetic factors, Na K ATPase activity and neuropathy in diabetics","volume":"181","author":"Vague","year":"1997","journal-title":"Bull. Acad. Natl. Med."},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0020","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.bbadis.2008.11.005","article-title":"Diabetes and the peripheral nerve","volume":"1792","author":"Obrosova","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0025","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s11064-012-0850-x","article-title":"Role of oxidative stress and Ca(2)(+) signaling on molecular pathways of neuropathic pain in diabetes: focus on TRP channels","volume":"37","author":"Naziroglu","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0030","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.2337\/diacare.27.9.2178","article-title":"Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy","volume":"27","author":"Ziegler","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0035","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.biochi.2012.01.023","article-title":"Suppression of NF-kappaB and NF-kappaB regulated oxidative stress and neuroinflammation by BAY 11-7082 (IkappaB phosphorylation inhibitor) in experimental diabetic neuropathy","volume":"94","author":"Kumar","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0040","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1210\/jc.2008-2385","article-title":"Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy","volume":"94","author":"Doupis","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0045","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/jcbfm.2012.190","article-title":"Subfield-specific neurovascular remodeling in the entorhino-hippocampal-organotypic slice culture as a response to oxygen-glucose deprivation and excitotoxic cell death","volume":"33","author":"Chip","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0050","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/jps.21946","article-title":"Feasibility study of aerosolized prostaglandin E1 microspheres as a noninvasive therapy for pulmonary arterial hypertension","volume":"99","author":"Gupta","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.diabres.2003.10.012","article-title":"Prostaglandin E1 in lipid microspheres ameliorates diabetic peripheral neuropathy: clinical usefulness of Semmes-Weinstein monofilaments for evaluating diabetic sensory abnormality","volume":"64","author":"Akahori","year":"2004","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0060","doi-asserted-by":"crossref","first-page":"805","DOI":"10.5551\/jat.3608","article-title":"Efficacy by ulcer type and safety of lipo-PGE1 for Japanese patients with diabetic foot ulcers","volume":"17","author":"Miyata","year":"2010","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0065","first-page":"955","article-title":"Prostaglandin E1 in stage III and IV arterial occlusive diseases. Results of a multicenter study","volume":"112","author":"Trubestein","year":"1987","journal-title":"Dtsch. Med. Wochenschr."},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0070","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.3892\/etm.2013.1061","article-title":"Therapeutic effect of liposomal prostaglandin E in acute lower limb ischemia as an adjuvant to hybrid procedures","volume":"5","author":"Li","year":"2013","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0075","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2337\/dc10-1303","article-title":"Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments","volume":"33","author":"Tesfaye","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0080","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1464-5491.2012.03644.x","article-title":"Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the diabetes control and complications trial\/epidemiology of diabetes interventions and complications","volume":"29","author":"Herman","year":"2012","journal-title":"Diabet. Med."},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0085","first-page":"307","article-title":"Prostacyclin and prostaglandin E1: molecular mechanisms and therapeutic utility","volume":"10","author":"Kerins","year":"1991","journal-title":"Prog. Hemost. Thromb."},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0090","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0090-6980(01)00165-4","article-title":"The therapeutic effect of lipo PGE1 on diabetic neuropathy-changes in endothelin and various angiopathic factors","volume":"66","author":"Itoh","year":"2001","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1536\/ihj.38.53","article-title":"Dose-effect relationships of prostaglandin E1 in severe endstage chronic heart failure","volume":"38","author":"Stanek","year":"1997","journal-title":"Jpn. Heart J."},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0100","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/00024382-200014020-00026","article-title":"Prostaglandin E1 reduces ischemia\/reperfusion injury by normalizing nitric oxide and superoxide release","volume":"14","author":"Huk","year":"2000","journal-title":"Shock"},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1291\/hypres.27.85","article-title":"Increase in peripheral blood flow by intravenous administration of prostaglandin E1 in patients with peripheral arterial disease, accompanied by up-regulation of hepatocyte growth factor","volume":"27","author":"Makino","year":"2004","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0110","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1097\/00003246-200007000-00004","article-title":"Prostaglandin E1 reduces myocardial reperfusion injury by inhibiting proinflammatory cytokines production during cardiac surgery","volume":"28","author":"Kawamura","year":"2000","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0115","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1213\/00000539-199709000-00006","article-title":"A comparative study of the vasodilator effects of prostaglandin E1 in patients with pulmonary hypertension after mitral valve replacement and with adult respiratory distress syndrome","volume":"85","author":"Kunimoto","year":"1997","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0120","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0012-3692(15)50417-0","article-title":"Effects of lipo-prostaglandin E1 on pulmonary hemodynamics and clinical outcomes in patients with pulmonary arterial hypertension","volume":"128","author":"Shen","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0125","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2459\/JCM.0b013e32834bb47c","article-title":"Protective effect of lipid microspheres 1 on myocardial injury following elective percutaneous coronary intervention in patients with angina pectoris: a pilot study","volume":"12","author":"Chu-fan","year":"2011","journal-title":"J. Cardiovasc. Med."},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0130","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.bbrc.2011.03.043","article-title":"Identification of gene variants in NOS3, ET-1 and RAS that confer risk and protection against microangiopathy in type 2 diabetic obese subjects","volume":"407","author":"Manea","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0135","first-page":"462","article-title":"Neuropathic pain in diabetes\u2014evidence for a central mechanism. Nature reviews","volume":"6","author":"Fischer","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0140","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jdiacomp.2015.08.001","article-title":"Clinical efficacy of different doses of lipo-prostaglandin E1 in the treatment of painful diabetic peripheral neuropathy","volume":"29","author":"Hong","year":"2015","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0145","first-page":"343","article-title":"Clinical observation of combined therapeutic effect of prostaglandin E1 and mecobalamin on diabetic peripheral neuropathy","volume":"26","author":"Zhu","year":"2001","journal-title":"Hunan Yi Ke Da Xue Xue Bao"},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0150","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neulet.2015.03.037","article-title":"Effects of prostaglandin E1 plus methylcobalamin alone and in combination with lipoic acid on nerve conduction velocity in patients with diabetic peripheral neuropathy: a meta-analysis","volume":"594","author":"Jiang","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0155","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2337\/diabetes.47.3.457","article-title":"Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration","volume":"47","author":"Veves","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0160","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2147\/VHRM.S3920","article-title":"The importance of endothelin-1 for microvascular dysfunction in diabetes","volume":"4","author":"Kalani","year":"2008","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0165","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1472-6823-13-32","article-title":"Effect of glycemic control on soluble RAGE and oxidative stress in type 2 diabetic patients","volume":"13","author":"Motawi","year":"2013","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0170","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0028-3908(02)00020-5","article-title":"Prostaglandin E1 protects cultured spinal neurons against the effects of nitric oxide toxicity","volume":"42","author":"Kikuchi","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.prostaglandins.2016.07.006_bib0175","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jconrel.2010.08.003","article-title":"Nano PGE1 promoted the recovery from spinal cord injury-induced motor dysfunction through its accumulation and sustained release","volume":"148","author":"Takenaga","year":"2010","journal-title":"J. Control. Release"}],"container-title":["Prostaglandins & Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882316300533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882316300533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T03:03:02Z","timestamp":1568170982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882316300533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":35,"alternative-id":["S1098882316300533"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2016.07.006","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PGE1 improves diabetic peripheral neuropathy in patients with type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2016.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}